GL1X · GenesisL1 explorer

MolNFT v1 · #47926 · protein

Human aldose reductase mutant L300P complexed with zopolrestat.

2PDF: “Human aldose reductase mutant L300P complexed with zopolrestat.”. X-ray diffraction, 2 ligands (NAP, ZST), 3 pockets (best druggability 0.73). MolNFT v1 #47926 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2PDF
Type
protein
Length
314 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aldose reductase
EC
1.1.1.21
UniProt
P15121
Ligands
NAP, ZST
Pockets
3 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAldose reductase (EC 1.1.1.21)protein31439% helix, 15% strandP15121

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • ZST · 3,4-dihydro-4-oxo-3-((5-trifluoromethyl-2-benzothiazolyl)methyl)-1-phthalazine acetic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13370.730.8553NAP, ZST
2510.340.7911empty
3530.310.7620empty

Compared structures

  • 2PDF · Human aldose reductase mutant L300P complexed with zopolrestat. · the same entry in another collection · chain A against A, TM-score 1.00
  • P15121 · AlphaFold monomer V2.0 prediction for aldo-keto reductase family 1 member B1 (P15121) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.